PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $215,136 | -31.8% | 101,003 | +18.5% | 0.00% | -50.0% |
Q4 2022 | $315,414 | +2326.3% | 85,247 | +492.0% | 0.00% | – |
Q1 2022 | $13,000 | +116.7% | 14,400 | +1948.4% | 0.00% | – |
Q4 2021 | $6,000 | -97.1% | 703 | -97.2% | 0.00% | -100.0% |
Q3 2021 | $207,000 | -18.5% | 24,761 | -34.3% | 0.00% | 0.0% |
Q2 2021 | $254,000 | +151.5% | 37,684 | +145.6% | 0.00% | +200.0% |
Q1 2021 | $101,000 | +531.2% | 15,345 | +1539.4% | 0.00% | 0.0% |
Q2 2015 | $16,000 | -94.4% | 936 | -92.8% | 0.00% | -92.9% |
Q1 2015 | $286,000 | – | 13,064 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |